C5 Inhibition in Secondary Thrombotic Microangiopathies: A Yet Unresolved Question

被引：2
|
作者：
Werion, Alexis [1 ]
Rondeau, Eric [1 ]
机构：
[1] Hop Tenon, AP HP, Intens Care Nephrol & Transplantat Dept, SINRA, Paris, France
来源：
KIDNEY INTERNATIONAL REPORTS | 2021年 / 6卷 / 04期
关键词：
COMPLEMENT INHIBITORS;
D O I：
10.1016/j.ekir.2021.02.012
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：878 / 880
页数：3
相关论文
共 50 条
  • [1] Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis-Induced Thrombotic Microangiopathies
    Gouin, Anna
    Ribes, David
    Colombat, Magali
    Chauveau, Dominique
    Prevot, Gregoire
    Lairez, Olivier
    Pugnet, Gregory
    Fremeaux-Bacchi, Veronique
    Huart, Antoine
    Belliere, Julie
    Faguer, Stanislas
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (04): : 1015 - 1021
  • [2] Complement C5 inhibition reverses bleomycin-induced thrombotic microangiopathy
    Salhi, Sofiane
    Ribes, David
    Faguer, Stanislas
    CLINICAL KIDNEY JOURNAL, 2021, 14 (04) : 1275 - 1276
  • [3] C5 inhibition allows continued antineoplastic therapy in cancerand chemotherapy-associated thrombotic microangiopathy
    Shah, Hridaya
    Chen, Hang
    Pan, Xiang-Zuo
    Metjian, Ara
    Brodsky, Robert A.
    Braunstein, Evan M.
    Chaturvedi, Shruti
    BLOOD ADVANCES, 2022, 6 (23) : 6071 - 6074
  • [4] Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea
    Brocklebank, Vicky
    Kavanagh, David
    CLINICAL KIDNEY JOURNAL, 2017, 10 (05) : 600 - 624
  • [5] C5 inhibition with eculizumab prevents thrombotic microangiopathy in a case series of pig-to-human kidney xenotransplantation
    Jones-Carr, Maggie E.
    Fatima, Huma
    Kumar, Vineeta
    Anderson, Douglas J.
    Houp, Julie
    Perry, Jackson C.
    Baker, Gavin A.
    Mcmanus, Leigh
    Shunk, Andrew J.
    Porrett, Paige M.
    Locke, Jayme E.
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (05):
  • [6] Structural basis for therapeutic inhibition of complement C5
    Matthijs M Jore
    Steven Johnson
    Devon Sheppard
    Natalie M Barber
    Yang I Li
    Miles A Nunn
    Hans Elmlund
    Susan M Lea
    Nature Structural & Molecular Biology, 2016, 23 : 378 - 386
  • [7] C5 inhibition in PNH: still effective and safe
    Szer, Jeff
    BLOOD, 2022, 143 (12) : 1064 - 1065
  • [8] Structural basis for therapeutic inhibition of complement C5
    Jore, Matthijs M.
    Johnson, Steven
    Sheppard, Devon
    Barber, Natalie M.
    Li, Yang I.
    Nunn, Miles A.
    Elmlund, Hans
    Lea, Susan M.
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2016, 23 (05) : 378 - 386
  • [9] Prevention of Acute Humoral Rejection with C5 Inhibition.
    Stegall, Mark D.
    Diwan, Tayyab S.
    Burns, Justin M.
    Dean, Patrick G.
    Cornell, Lynn D.
    Gandhi, Manish J.
    Cosio, Fernando G.
    Gloor, James M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 241 - 242
  • [10] Structural insight into eculizumab mediated inhibition of C5 cleavage
    Schatz-Jakobsen, Janus A.
    Sun, Fang
    Sheridan, Douglas
    Andersen, Gregers R.
    MOLECULAR IMMUNOLOGY, 2015, 67 (01) : 179 - 179
12345